Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-025388

Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)

  • Chief Financial Officer acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Cohen Chad M Chief Financial Officer 2020-04-20 Option exercise +10,000 $4.07 $40,700 11,000 D: show line 1 in the form
Cohen Chad M Chief Financial Officer 2020-04-20 Sale −10,000 $30.00 $300,000 1,000 D: show line 2 in the form
Open-market sales · 10,000 sh · avg $30.00 · $300,000

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Cohen Chad M Chief Financial Officer 2020-04-20 Option exercise · Stock Option (Right to Buy) −10,000 20,000 D: show line 3 in the form
Loading xslF345X03/doc4.xml…